Immage Biotherapeutics Corp. (IMMG)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 22, 2026
Immage Biotherapeutics Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IMMG has 151.74 million shares outstanding.
| Current Share Class | 151.74M |
| Shares Outstanding | 151.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.45% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 2.52.
| Current Ratio | 0.83 |
| Quick Ratio | 0.78 |
| Debt / Equity | 2.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,133.57% and return on invested capital (ROIC) is -529.47%.
| Return on Equity (ROE) | -1,133.57% |
| Return on Assets (ROA) | -496.11% |
| Return on Invested Capital (ROIC) | -529.47% |
| Return on Capital Employed (ROCE) | -8,180.64% |
| Weighted Average Cost of Capital (WACC) | 0.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -456,950 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 51.35 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 45.71 |
| Average Volume (20 Days) | 16,619 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.83M |
| Pretax Income | -1.83M |
| Net Income | -1.83M |
| EBITDA | -1.82M |
| EBIT | -1.83M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 53,687 in cash and 56,267 in debt, with a net cash position of -2,580 or -0.00 per share.
| Cash & Cash Equivalents | 53,687 |
| Total Debt | 56,267 |
| Net Cash | -2,580 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 22,343 |
| Book Value Per Share | 0.00 |
| Working Capital | -11,449 |
Cash Flow
| Operating Cash Flow | -274,083 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 8,162 |
| Net Borrowing | -375,000 |
| Free Cash Flow | -274,083 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IMMG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.13% |
| Shareholder Yield | -20.13% |
| Earnings Yield | -1,228,700.00% |
| FCF Yield | -180,317.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |